Areas of Interest


  • The clinical awareness of acute treatment options for migraine and differentiations in a patient-centric clinical practice
  • The unmet needs within migraine and unique treatment options
  • NSAIDs safety and efficacy including the role of NSAIDs in neurogenic pathways of migraine

Chronic Pain

  • The clinical impact and cost reduction of abuse deterrent formulations and atypical opioids to overall healthcare costs for chronic pain patients specific to abuse and addiction.
  • The process and clinical impact of transitioning chronic-pain patients to alternative therapy options
  • Abuse deterrent formulations and atypical opioids and their impact on healthcare and patient outcomes


Preferred method of follow-up?*

*This form is not for Adverse Event Reporting. Please see information above.